olmesartan medoxomil and hydrochlorothiazide

Generic: olmesartan medoxomil and hydrochlorothiazide

Labeler: ascend laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olmesartan medoxomil and hydrochlorothiazide
Generic Name olmesartan medoxomil and hydrochlorothiazide
Labeler ascend laboratories, llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

hydrochlorothiazide 12.5 mg/1, olmesartan medoxomil 40 mg/1

Manufacturer
Ascend Laboratories, LLC

Identifiers & Regulatory

Product NDC 67877-452
Product ID 67877-452_e6461d60-f7cc-454e-b54e-2bcbcb64e631
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207037
Listing Expiration 2026-12-31
Marketing Start 2025-05-01

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67877452
Hyphenated Format 67877-452

Supplemental Identifiers

RxCUI
403853 403854 403855
UPC
0367877453903 0367877452906 0367877451305
UNII
0J48LPH2TH 6M97XTV3HD
NUI
N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olmesartan medoxomil and hydrochlorothiazide (source: ndc)
Generic Name olmesartan medoxomil and hydrochlorothiazide (source: ndc)
Application Number ANDA207037 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
  • 40 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (67877-452-30)
  • 90 TABLET, FILM COATED in 1 BOTTLE (67877-452-90)
source: ndc

Packages (2)

Ingredients (2)

hydrochlorothiazide (12.5 mg/1) olmesartan medoxomil (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e6461d60-f7cc-454e-b54e-2bcbcb64e631", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0367877453903", "0367877452906", "0367877451305"], "unii": ["0J48LPH2TH", "6M97XTV3HD"], "rxcui": ["403853", "403854", "403855"], "spl_set_id": ["798fee33-51ad-45d0-82f3-09289304139f"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (67877-452-30)", "package_ndc": "67877-452-30", "marketing_start_date": "20250501"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (67877-452-90)", "package_ndc": "67877-452-90", "marketing_start_date": "20250501"}], "brand_name": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE", "product_id": "67877-452_e6461d60-f7cc-454e-b54e-2bcbcb64e631", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "67877-452", "generic_name": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA207037", "marketing_category": "ANDA", "marketing_start_date": "20250501", "listing_expiration_date": "20261231"}